(Q31095655)

28 June 2017

title

The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine (English)

1 reference

28 June 2017

D M Weiner

1

1 reference

28 June 2017

H Y Meltzer

2

1 reference

28 June 2017

I Veinbergs

3

1 reference

28 June 2017

E M Donohue

4

1 reference

28 June 2017

T A Spalding

5

1 reference

28 June 2017

T T Smith

6

1 reference

28 June 2017

N Mohell

7

1 reference

28 June 2017

S C Harvey

8

1 reference

28 June 2017

J Lameh

9

1 reference

28 June 2017

N Nash

10

1 reference

28 June 2017

K E Vanover

11

1 reference

28 June 2017

R Olsson

12

1 reference

28 June 2017

K Jayathilake

13

1 reference

28 June 2017

M Lee

14

1 reference

28 June 2017

A I Levey

15

1 reference

28 June 2017

U Hacksell

16

1 reference

28 June 2017

E S Burstein

17

1 reference

28 June 2017

R E Davis

18

1 reference

28 June 2017

M R Brann

19

1 reference

28 June 2017

publication date

16 July 2004

1 reference

28 June 2017

1 reference

28 June 2017

volume

177

1 reference

28 June 2017

issue

1-2

1 reference

28 June 2017

page(s)

207-216

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-004-1940-5

28 June 2017

exact match

0 references

cites work

Identification of a family of muscarinic acetylcholine receptor genes

1 reference

12 December 2020

G-protein-coupled receptor-mediated activation of rap GTPases: characterization of a novel Galphai regulated pathway

1 reference

12 December 2020

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

12 December 2020

Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice.

1 reference

12 December 2020

Functional partial agonism at cloned human muscarinic acetylcholine receptors.

1 reference

12 December 2020

Discovery of an ectopic activation site on the M(1) muscarinic receptor

1 reference

12 December 2020

CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study.

1 reference

12 December 2020

Clozapine. A novel antipsychotic agent

1 reference

12 December 2020

Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice

1 reference

12 December 2020

Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia

1 reference

12 December 2020

Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine‐induced seizure activity

1 reference

12 December 2020

M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices.

1 reference

12 December 2020

Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.

1 reference

12 December 2020

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

12 December 2020

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

1 reference

12 December 2020

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

1 reference

12 December 2020

The metabolism of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e) (1,4)diazepine (clozapine) in mice, dogs and human subjects

1 reference

12 December 2020

A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.

1 reference

12 December 2020

Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking

1 reference

12 December 2020

5-hydroxytryptamine2A receptor inverse agonists as antipsychotics

1 reference

12 December 2020

Therapeutic intervention in dementia

1 reference

12 December 2020

Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors

1 reference

12 December 2020

Distribution of clozapine and desmethylclozapine between blood and brain in rats.

1 reference

12 December 2020

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

1 reference

12 December 2020

Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients

1 reference

12 December 2020

Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells

1 reference

12 December 2020

Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia

1 reference

12 December 2020

The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain.

1 reference

12 December 2020

Antipsychotic drugs, neurotransmitters, and schizophrenia

1 reference

12 December 2020

Tissue concentrations of clozapine and its metabolites in the rat

1 reference

12 December 2020

Effects of desmethylclozapine on Fos protein expression in the forebrain: in vivo biological activity of the clozapine metabolite

1 reference

12 December 2020

Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophrenia.

1 reference

12 December 2020

Clozapine is a potent and selective muscarinic M4 receptor agonist

1 reference

12 December 2020

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

1 reference

12 December 2020

Pirenzepine for clozapine-induced hypersalivation

1 reference

12 December 2020

N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl- d -aspartate receptor activity

1 reference

12 December 2020

Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia

1 reference

12 December 2020

Predictors of clinical outcome in schizophrenic patients responding to clozapine

1 reference

12 December 2020

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

1 reference

12 December 2020

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H(3) receptor

1 reference

12 December 2020

Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection

1 reference

12 December 2020

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

1 reference

12 December 2020

Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells

1 reference

12 December 2020

Schizophrenia: from phenomenology to neurobiology

1 reference

12 December 2020

Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists.

1 reference

12 December 2020

10.1007/S00213-004-1940-5

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

1014059433

0 references

1 reference